Journal articleHuman

[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]

Bioorganicheskaia khimiia, 2001 May-Jun. Kost NV, Sokolov OIu, Gabaeva MV and 4 others.

Study type

Journal article

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Bioorganicheskaia khimiia

Published

2001 May-Jun

PubMed

PMID 11443939 ↗

DOI

10.1023/a:1011373002885 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Semax →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Adrenocorticotropic HormoneDose-Response Relationship, DrugEnzyme InhibitorsHumansNeprilysinOligopeptidesPeptide Fragments

Other papers on Semax

Clinical trial · 2018

[The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

Journal article · 2006

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page